Department of Obstetrics and Gynaecology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Die Arbeit des Jungen Forum in der DGGG e. V. Wer wir sind - Was wir gemeinsam erreichen können! (2023) Amann N, Becker L, Göpfert M, Kießling N, Tauber N Journal article ChatGPT’s performance in German OB/GYN exams – paving the way for AI-enhanced medical education and clinical practice (2023) Riedel M, Kaefinger K, Stuehrenberg A, Ritter V, Amann N, Graf A, Recker F, et al. Journal article Kontrazeption – neue Trends, auch für Jugendliche (2023) Pontones C, Oppelt P Journal article Update Breast Cancer 2023 Part 2 - Advanced-Stage Breast Cancer. (2023) Lux MP, Hartkopf AD, Fehm TN, Welslau M, Müller V, Schütz F, Fasching P, et al. Journal article Learning laparoscopic hysterectomy: analysis of different surgeons' individual learning curves (2022) Schutzenduebel M, Boosz A, Baev E, Häberle L, Muller A Journal article Sarcoma of the UterusGuideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021) (2022) Denschlag D, Ackermann S, Battista MJ, Cremer W, Egerer G, Fehr M, Follmann M, et al. Journal article Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (Breast Cancer Research, (2022), 24, 1, (69), 10.1186/s13058-022-01567-3) (2022) Giardiello D, Hooning MJ, Hauptmann M, Keeman R, Heemskerk-Gerritsen BA, Becher H, Blomqvist C, et al. Journal article, Erratum Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic triple-negative breast cancer that expresses PD-L1 (2022) Huang M, O'Shaughnessy J, Haiderali A, Pan W, Hu P, Chaudhuri M, Le Bailly De Tilleghem C, et al. Journal article A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE) (2022) Schmidt M, Lübbe K, Decker T, Thill M, Bauer L, Müller V, Link T, et al. Journal article PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (2022) Giardiello D, Hooning MJ, Hauptmann M, Keeman R, Heemskerk-Gerritsen BAM, Becher H, Blomqvist C, et al. Journal article